propranolol has been researched along with Hypertrophy, Right Ventricular in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
Excerpt | Relevance | Reference |
---|---|---|
"The study consisted of six groups (N=30; five rabbits/group): (1) Control with no pretreatment, monocrotaline injected groups: (solutions were perfused following termination of CPB for 60 min); (2) Control for pulmonary hypertension (PHT); (3) isoproteronol; (4) VIP 10(-6) M; (5) VIP 10(-5) M; (6) nitroglycerine." | 3.71 | The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine. ( Chang, D; Gunaydin, S; Hagino, I; Imai, Y; Seo, K; Shinoka, T; Takanashi, Y, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ostman-Smith, I | 1 |
Gunaydin, S | 1 |
Imai, Y | 1 |
Takanashi, Y | 1 |
Seo, K | 1 |
Hagino, I | 1 |
Chang, D | 1 |
Shinoka, T | 1 |
Mill, JG | 1 |
Leite, DV | 1 |
Novaes, MA | 1 |
Lima-Pereira, FE | 1 |
Vassallo, DV | 1 |
3 other studies available for propranolol and Hypertrophy, Right Ventricular
Article | Year |
---|---|
Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; | 1995 |
The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Cardiopulm | 2002 |
Propranolol reduces myocardial hypertrophy in the right cardiac chambers after infarction in rats.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Heart; Hypertro | 1992 |